SCHEMBL3852371

SCHEMBL3852371

Cc1c(-c2ccccc2)n(C)c2ccc(Br)cc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 1/20 0.47
CCNB2 O95067 1/20 0.43
CDK1 P06493 1/20 0.43
CCNB1 P14635 1/20 0.43
GSK3B P49841 1/20 0.43
CCNB3 Q8WWL7 1/20 0.43
ALDH1A1 P00352 5/20 0.43
LMNA P02545 2/20 0.43
GRIK2 Q13002 1/20 0.43
HSD17B10 Q99714 2/20 0.42
CYP2C19 P33261 1/20 0.42
L3MBTL1 Q9Y468 4/20 0.41
HPGD P15428 3/20 0.41
ATM Q13315 3/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
EGFR P00533 1/20 0.41
SRC P12931 1/20 0.41
KDM4E B2RXH2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19052340 0.83 MEN1 (0.50) CYP11B2ALDH1A1LMNAGRIK2HSD17B10
SCHEMBL7815329 0.83 CYP11B2 (0.68) CYP11B2HSD17B10CYP2C19KMT2AKDM4E
SCHEMBL22005104 0.81 KDM4E (0.50) CYP11B2ALDH1A1LMNAGRIK2HSD17B10
SCHEMBL28811227 0.80 CYP11B2 (0.56) CYP11B2ALDH1A1LMNAGRIK2HSD17B10
SCHEMBL10067380 0.79 CYP11B2 (0.68) CYP11B2ALDH1A1LMNAHSD17B10CYP2C19
SCHEMBL28282805 0.79 CCNB2 (0.43) CCNB2CDK1CCNB1GSK3BCCNB3
SCHEMBL3856618 0.78 PPARG (0.51) CCNB2CDK1CCNB1GSK3BCCNB3
SCHEMBL3855156 0.78 GRIK2 (0.50) ALDH1A1LMNAGRIK2CYP2C19MEN1
SCHEMBL3854575 0.78 ALDH1A1 (0.49) ALDH1A1LMNAHSD17B10HPGDSMN1; SMN2
SCHEMBL3856953 0.77 ESR1 (0.52) CYP11B2ALDH1A1LMNAGRIK2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7582773-B2 Substituted phenyl indoles WYETH (US) 2009-09-01 US disclosed
US-20050070592-A1 Substituted phenyl indoles WYETH (US) 2005-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050070592-A1 Substituted phenyl indoles TPH2, IDO2, AANAT CYP11B2 141/4885CCNB2 1115/4885CDK1 1265/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.